Aβ42-lowering Nonsteroidal Anti-inflammatory Drugs Preserve Intramembrane Cleavage of the Amyloid Precursor Protein (APP) and ErbB-4 Receptor and Signaling through the APP Intracellular Domain
Sascha Weggen(Heinrich Heine University Düsseldorf), Edward H. Koo(National University of Singapore)
Cited by 125
Related Papers
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
|Alzheimer s & Dementia|2020|516
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264
Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma
|Biochemical and Biophysical Research Communications|2000|226
N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
|Alzheimer s Research & Therapy|2017|64
Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1
|Journal of Biological Chemistry|2023|3